Activated mTORC1 signaling: The common driving force of type 2 diabetes and hidradenitis suppurativa

被引:12
作者
De Vita, Valerio [1 ]
Melnik, Bodo C. [2 ]
机构
[1] Univ Naples Federico II, Dermatol Unit, Via Sergio Pansini 5, I-80131 Naples, Italy
[2] Univ Osnabruck, Dept Dermatol Environm Med & Hlth Theory, Osnabruck, Germany
关键词
D O I
10.1016/j.jaad.2017.11.061
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E121 / E121
页数:1
相关论文
共 6 条
[1]   TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists [J].
Blagosklonny, M. V. .
CELL DEATH & DISEASE, 2013, 4 :e964-e964
[2]   The Magnitude of mTORC1 Signalling May Predict the Response to Isotretinoin Treatment in Patients with Hidradenitis Suppurativa [J].
De Vita, Valerio ;
Melnik, Bodo C. .
DERMATOLOGY, 2017, 233 (05) :399-400
[3]   Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents [J].
Matusiak, Lukasz ;
Szczech, Justyna ;
Bieniek, Andrzej ;
Nowicka-Suszko, Danuta ;
Szepietowski, Jacek C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) :670-675
[4]   Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop [J].
Monfrecola, G. ;
Balato, A. ;
Caiazzo, G. ;
De Vita, V. ;
Di Caprio, R. ;
Donnarumma, M. ;
Lembo, S. ;
Fabbrocini, G. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (09) :1631-1633
[5]   Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders [J].
Owczarczyk-Saczonek, Agnieszka ;
Placek, Waldemar .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (03) :260-268
[6]   Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis [J].
Thanh-Lan Bui ;
Silva-Hirschberg, Catalina ;
Torres, Josefina ;
Armstrong, April W. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (02) :395-402